These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27861217)

  • 41. Post-thymectomy combined treatment of prednisone and tacrolimus versus prednisone alone for consolidation of complete stable remission in patients with myasthenia gravis: a non-randomized, non-controlled study.
    Ponseti JM; Gamez J; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Armengol M
    Curr Med Res Opin; 2007 Jun; 23(6):1269-78. PubMed ID: 17559724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of Thymectomy on Crisis Incidence and Quality of Life amongst Generalised Myasthenia Gravis Patients.
    Kanikannan MA; Reddy PK; Mathukumalli NL; Yareeda S; Borgohain R
    Neurol India; 2022; 70(6):2427-2431. PubMed ID: 36537428
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thoracoscopic thymectomy mid-term results.
    Tomulescu V; Ion V; Kosa A; Sgarbura O; Popescu I
    Ann Thorac Surg; 2006 Sep; 82(3):1003-7. PubMed ID: 16928524
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Video-assisted thoracic surgery thymectomy for nonthymomatous myasthenia gravis.
    Manlulu A; Lee TW; Wan I; Law CY; Chang C; Garzon JC; Yim A
    Chest; 2005 Nov; 128(5):3454-60. PubMed ID: 16304299
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Thymectomy for myastenia gravis: 25-year experience].
    Petkov R; Kŭtev N; Mladenovski V; Todorov G; Gavrilov N; Atanasov A; Goranov N
    Khirurgiia (Sofiia); 2004; 60(3):27-9. PubMed ID: 15702874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resistant myasthenia gravis and rituximab: A monocentric retrospective study of 28 patients.
    Afanasiev V; Demeret S; Bolgert F; Eymard B; Laforêt P; Benveniste O
    Neuromuscul Disord; 2017 Mar; 27(3):251-258. PubMed ID: 28082209
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Remission And relapse of myasthenia gravis on long-term azathioprine: An ambispective study.
    Gupta A; Goyal V; Srivastava AK; Shukla G; Behari M
    Muscle Nerve; 2016 Sep; 54(3):405-12. PubMed ID: 26802912
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability.
    Meriggioli MN; Ciafaloni E; Al-Hayk KA; Rowin J; Tucker-Lipscomb B; Massey JM; Sanders DB
    Neurology; 2003 Nov; 61(10):1438-40. PubMed ID: 14638974
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Robotic-assisted thymectomy with Da Vinci II versus sternotomy in the surgical treatment of non-thymomatous myasthenia gravis: early results.
    Renaud S; Santelmo N; Renaud M; Fleury MC; De Seze J; Tranchant C; Massard G
    Rev Neurol (Paris); 2013 Jan; 169(1):30-6. PubMed ID: 22682054
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors influencing the outcome of transsternal thymectomy for myasthenia gravis.
    Huang CS; Hsu HS; Huang BS; Lee HC; Kao KP; Hsu WH; Huang MH
    Acta Neurol Scand; 2005 Aug; 112(2):108-14. PubMed ID: 16008537
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Juvenile myasthenia gravis and thymectomy: report of ten cases.
    de Assis JL; Marchiori PE; Zambon AA; Scaff M
    Rev Hosp Clin Fac Med Sao Paulo; 1992; 47(5):234-6. PubMed ID: 1340608
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictive factors of prolonged mechanical ventilation, overall survival, and quality of life in patients with post-thymectomy myasthenic crisis.
    Li KK; Qian K; Feng YG; Guo W; Tan QY; Deng B
    World J Surg Oncol; 2017 Aug; 15(1):150. PubMed ID: 28789662
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The long-term results of thymectomy for myasthenia gravis].
    Nakamura H; Fukuda M; Suzuki Y; Taniguchi Y; Tanaka Y; Ishiguro K; Hara H; Mori T
    Kyobu Geka; 1995 Mar; 48(3):184-9. PubMed ID: 7897895
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extended transsternal thymectomy for myasthenia gravis: a report of 19 consecutive cases.
    Durieux R; Radermecker MA; Dekoster G; Limet R
    Acta Chir Belg; 2008; 108(1):102-6. PubMed ID: 18411583
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term outcome and factors influencing the outcome of thymectomy for myasthenia gravis.
    Witoonpanich R; Dejthevaporn C; Srisinroongruang T; Subhannachart W; Attanavanich S; Boonkasem S; Thakkinstian A
    J Med Assoc Thai; 2004 Oct; 87(10):1172-5. PubMed ID: 15560693
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term follow-up after thymectomy for myasthenia gravis: thoracoscopic vs open.
    Wagner AJ; Cortes RA; Strober J; Grethel EJ; Clifton MS; Harrison MR; Farmer DL; Nobuhara KK; Lee H
    J Pediatr Surg; 2006 Jan; 41(1):50-4; discussion 50-4. PubMed ID: 16410107
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thoracoscopic thymectomy with the da Vinci robotic system for myasthenia gravis.
    Rückert JC; Ismail M; Swierzy M; Sobel H; Rogalla P; Meisel A; Wernecke KD; Rückert RI; Müller JM
    Ann N Y Acad Sci; 2008; 1132():329-35. PubMed ID: 18567884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rituximab as induction therapy in refractory myasthenia gravis: 18 month follow-up study.
    Singh N; Goyal V
    J Neurol; 2019 Jul; 266(7):1596-1600. PubMed ID: 30919039
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thymectomy in the treatment of ocular myasthenia gravis.
    Roberts PF; Venuta F; Rendina E; De Giacomo T; Coloni GF; Follette DM; Richman DP; Benfield JR
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):562-8. PubMed ID: 11547310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thymectomy for myasthenia gravis: prognostic factors in 70 patients.
    Aghajanzadeh M; Khoshrang H; Mohammadzadeh A; Roudbari SA; Ghayeghran AR
    Asian Cardiovasc Thorac Ann; 2007 Oct; 15(5):371-5. PubMed ID: 17911062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.